Russell Investments Group, Ltd.

Position in OVID — Ovid Therapeutics Inc.

CIK 1692234 Seattle, WA

Position in OVID

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$32,871

+$32,454 QoQ

Shares Held

12,220

+2633.8% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#105

of 130 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. OVID ranks #247 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,871	12,220	+2633.8%	Shares	Defined	2026-08-06
2024-12-31	$417	447	-74.7%	Shares	Defined	2025-02-13
2024-09-30	$2,081	1,764	+10.4%	Shares	Defined	2024-11-13
2024-06-30	$1,228	1,598	+2703.5%	Shares	Defined	2024-08-08
2023-09-30	$218	57	-100.0%	Shares	Defined	2023-11-13
2023-03-31	$690,042	267,459	-0.5%	Shares	Defined	2023-05-09
2022-12-31	$499,808	268,715	0.0%	Shares	Defined	2023-02-08
2022-09-30	$494,434	268,715	+0.3%	Shares	Defined	2022-11-04
2022-06-30	$575,914	267,868	-2.9%	Shares	Defined	2022-07-29
2022-03-31	$866,553	275,973	-10.0%	Shares	Defined	2022-05-05
2021-12-31	$984,043	306,556	+194.0%	Shares	Sole	2022-01-21
2021-03-31	$419,217	104,283	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.